Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002167619 | SCV002337614 | benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002167619 | SCV002497692 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | NAXD: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV002167619 | SCV005218339 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003923466 | SCV004746270 | likely benign | NAXD-related disorder | 2019-05-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |